# A Study to Assess the Safety of Adacel® Vaccine

> **NCT01040052** · PHASE3 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 30 (actual)

## Conditions studied

- Diphtheria
- Tetanus
- Pertussis

## Interventions

- **BIOLOGICAL:** Adacel® (Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis)

## Key facts

- **NCT ID:** NCT01040052
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-02
- **Final completion:** 2010-04
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2016-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01040052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01040052, "A Study to Assess the Safety of Adacel® Vaccine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01040052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*